HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junfeng Shi Selected Research

defactinib

12/2020BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways.
1/2020Epigenetic Input Dictates the Threshold of Targeting of the Integrin-Dependent Pathway in Non-small Cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Junfeng Shi Research Topics

Disease

39Neoplasms (Cancer)
01/2022 - 09/2009
11Breast Neoplasms (Breast Cancer)
01/2022 - 06/2012
5Stomach Neoplasms (Stomach Cancer)
09/2022 - 01/2017
4Glioma (Gliomas)
01/2022 - 01/2016
4Carcinoma (Carcinomatosis)
01/2021 - 01/2017
4Neoplasm Metastasis (Metastasis)
01/2020 - 07/2014
3Stroke (Strokes)
01/2021 - 06/2019
3Inflammation (Inflammations)
10/2020 - 01/2013
3Adenocarcinoma
01/2020 - 06/2018
3Pancreatic Neoplasms (Pancreatic Cancer)
07/2019 - 11/2017
3Glioblastoma (Glioblastoma Multiforme)
01/2018 - 10/2014
2Wounds and Injuries (Trauma)
04/2022 - 10/2018
2Carcinogenesis
01/2021 - 10/2020
2Triple Negative Breast Neoplasms
12/2020 - 08/2017
2Prostatic Neoplasms (Prostate Cancer)
01/2020 - 06/2018
2Colorectal Neoplasms (Colorectal Cancer)
04/2017 - 01/2017
2Insulin Resistance
06/2015 - 03/2014
2Glomerulonephritis
01/2015 - 01/2015
1Diabetes Mellitus
04/2022
1Kidney Diseases (Kidney Disease)
01/2022
1Obesity
01/2022
1Mesothelioma
11/2021
1Residual Neoplasm
11/2021
1Squamous Cell Neoplasms (Squamous Cell Cancer)
08/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2021
1Body Weight (Weight, Body)
06/2021
1Non-alcoholic Fatty Liver Disease
01/2021
1Ischemic Stroke
01/2021
1COVID-19
11/2020
1Alzheimer Disease (Alzheimer's Disease)
10/2020
1Neuroinflammatory Diseases
10/2020
1Cerebral Hemorrhage
01/2020

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2014
9Peptides (Polypeptides)IBA
11/2021 - 10/2015
7Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
7Pharmaceutical PreparationsIBA
01/2022 - 09/2009
7Messenger RNA (mRNA)IBA
01/2020 - 11/2017
5EnzymesIBA
08/2017 - 10/2015
4HydrogelsIBA
04/2022 - 07/2014
4Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 06/2012
4MicroRNAs (MicroRNA)IBA
11/2021 - 01/2016
4IntegrinsIBA
12/2020 - 07/2019
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2020 - 07/2014
3LigandsIBA
01/2020 - 01/2017
2empagliflozinIBA
01/2022 - 01/2021
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2022 - 12/2021
2CreatinineIBA
06/2021 - 01/2015
2Cadherins (E-Cadherin)IBA
01/2021 - 01/2020
2Long Noncoding RNAIBA
01/2021 - 01/2020
2Biological ProductsIBA
01/2021 - 12/2020
2defactinibIBA
12/2020 - 01/2020
2Receptor Tyrosine Kinase-like Orphan ReceptorsIBA
10/2020 - 01/2020
2Transcription Factors (Transcription Factor)IBA
01/2020 - 01/2019
2DipeptidesIBA
08/2017 - 10/2014
2ElementsIBA
06/2015 - 03/2014
2Sterol Regulatory Element Binding Protein 1IBA
06/2015 - 03/2014
2SterolsIBA
06/2015 - 03/2014
1Trastuzumab (Herceptin)FDA Link
09/2022
1Therapeutic UsesIBA
09/2022
1Platelet-Derived Growth FactorIBA
04/2022
1Anti-Infective Agents (Microbicides)IBA
04/2022
1CollagenIBA
04/2022
1InflammasomesIBA
01/2022
1tegaserod (Zelnorm)FDA Link
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1CateninsIBA
01/2022
1AdiponectinIBA
01/2022
1Hormones (Hormone)IBA
01/2022
1NF-kappa B (NF-kB)IBA
12/2021
1Leucine-Rich Repeat ProteinsIBA
12/2021
1EndostatinsIBA
08/2021
1sintilimabIBA
08/2021
1endostar proteinIBA
08/2021
1130-nm albumin-bound paclitaxelIBA
08/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1Sodium-Glucose Transport ProteinsIBA
01/2021
1RutheniumIBA
01/2021
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021
1FluvastatinFDA Link
01/2021
1VimentinIBA
01/2021
1Triglycerides (Triacylglycerol)IBA
01/2021
1apatinibIBA
01/2021
1Protein Kinases (Protein Kinase)IBA
12/2020
1AerosolsIBA
11/2020
1Amyloid (Amyloid Fibrils)IBA
10/2020
1p38 Mitogen-Activated Protein KinasesIBA
10/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
10/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2020
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2020
1engeletinIBA
10/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1camrelizumabIBA
01/2020
1PanobinostatIBA
01/2020
1Focal Adhesion Protein-Tyrosine KinasesIBA
01/2020

Therapy/Procedure

20Therapeutics
04/2022 - 01/2013
4Drug Therapy (Chemotherapy)
01/2021 - 08/2017
3Immunotherapy
01/2022 - 06/2018
1Cell- and Tissue-Based Therapy (Cell Therapy)
04/2022
1Precision Medicine
01/2021
1Secondary Prevention
01/2021